Page 11 - Assay Development News Today

Determining protein bioactivity/functionality using cell-based and biochemical-based assays

/PRNewswire/ -- The "Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow; By Mode; By Services; By Regions; Segment...

Product News: Bio-Rad has launched the SEQuoia RiboDepletion Kit for next-generation sequencing 13 May 2021 Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, has announced the launch of the SEQuoia RiboDepletion Kit, which promises to improve assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-seq library.  The SEQuoia RiboDepletion Kit is designed for genomics researchers targeting rare transcripts or work...

REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapys 24th Annual Meeting News provided by Share this article Share this article ROCKVILLE, Md., April 27, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapys 24 th Annual Meeting taking place from May 11 to 14, 2021, in virtual format. Presentations and posters will be available at https://...

The Native Antigen Company, part of LGC Clinical Diagnostics and one of the world’s leading suppliers of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, today announced the launch of its SARS-CoV-2 Neutralisation Assay Development Kit. The kit can be used to identify and qualitatively assess the ability of antibodies to neutralize SARS-CoV-2-receptor binding, to support research into variants and their effects on natural and vaccine-i...

Entheon Biomedical Corp. Launches HaluGens Psychedelics Genetic Test HaluGens DNA genetic testing provides insights into the sensitivity and risks associated with psychedelic-assisted psychotherapy Vancouver, British Columbia--(Newsfile Corp. - April 6, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces the launch of the industrys first Psychedelics Genetic Test ...

Derek Thomson, Chief Executive Officer at AnteoTech. AnteoTech’s AnteoBind™ Supports First-of-its-Kind COVID-19 Home Test     Feb 23 2021 Read 941 Times AnteoTechs long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its COVID-19 home test. The test uses AnteoTech’s unique AnteoBind™ technology to support significantly improved sensitivity, and is the first rapid s...

Share this article Share this article ResearchAndMarkets.coms offering. In light of the COVID-19 pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number of diseases currently tracking as moving from the developed world to the developing world? Now with a globa...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Allen Institute For Cell Science Announces Leadership Changes December 11, 2020 GMT SEATTLE, Wash., Dec. 11, 2020 /PRNewswire/ -- The Allen Institute for Cell Science, a division of the Allen Institute, announced today that Ruwanthi (Ru) Gunawardane, Ph.D., has been named Executive Director, effective January 9, 2021, providing executive direction and leadership. Susanne Rafelski, Ph.D., Deputy Director,...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Biofidelity appoints Robert Osborne as Chief Operating Officer Biofidelity LimitedDecember 10, 2020 GMT CAMBRIDGE, United Kingdom, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the further expansion of its leadership team with the appointment of Dr. Robert Osborne as Chief Operating Officer. In addition to responsibility for the overall operation of...